Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Viekira Pak
Viekira Pak
White House urged to stop states' 'rationing' of hep C drugs
Fierce Pharma
Wed, 08/26/15 - 11:56 am
hepatitis C
Medicaid
Harvoni
Gilead Sciences
AbbVie
Viekira Pak
Merck Targets Toughest Cases to Gain Hepatitis C Foothold
Bloomberg
Mon, 08/3/15 - 05:10 pm
Merck
Gilead Sciences
AbbVie
hepatitis C
Viekira Pak
Harvoni
Sovaldi
grazoprevir/elbasvir
AbbVie: Hep-C Sales Will Be Better Than Expected
Barron's
Tue, 07/21/15 - 01:00 pm
hepatitis C
Viekira Pak
Fast-paced changes in drugs for hepatitis C seen as harbinger of rising US health care costs
Yahoo/AP
Sat, 07/11/15 - 10:20 am
drug pricing
hepatitis C
Harvoni
Sovaldi
AbbVie
Gilead Sciences
Viekira Pak
Gilead Sciences: Does Anyone Care About Hep-C Anymore?
Barron's
Fri, 07/10/15 - 01:43 pm
Gilead Sciences
hepatitis C
AbbVie
Harvoni
Sovaldi
Viekira Pak
AbbVie hepatitis C cocktail succeeds in late-stage study
Reuters
Wed, 06/24/15 - 10:20 am
AbbVie
hepatitis C
Viekira Pak
AbbVie Pushing Hepatitis C Pipeline, But Is It Fast Enough?
Seeking Alpha
Wed, 04/29/15 - 09:57 am
AbbVie
hepatitis C
Viekira Pak
Japan
Europe
AbbVie moves closer to Japan's crowded hep C field with priority review nod
Fierce Pharma
Fri, 04/17/15 - 10:33 am
AbbVie
Japan
hepatitis C
Viekira Pak
Is Gilead Sciences Inc. About to Crater Before Our Very Eyes?
Motley Fool
Sun, 03/29/15 - 11:53 am
Gilead Sciences
hepatitis C
Harvoni
Sovaldi
AbbVie
Viekira Pak
11 promising drugs poised to be the next billion-dollar blockbusters
Yahoo/Business Insider
Sat, 03/28/15 - 10:26 am
Opdivo
Praluent
LCZ696
lumacaftor
Viekira Pak
evolocumab
Gardasil 9
brexpiprazole
Toujeo
Cosentyx
Bristol-Myers Squibb
Regeneron
Sanofi
Novartis
Pfizer
AbbVie
Amge
Astellas
Merck
Otsuka
Lundbeck
Vertex Pharmaceuticals
Why 2015 is the year of the biopharma blockbuster—with charts
BioPharma Dive
Tue, 03/24/15 - 10:29 am
biotech
Opdivo
Praluent
LCZ696
Ibrance
Viekira Pak
evolocumab
Gardasil 9
Bristol-Myers Squibb
Regeneron
Sanofi
Novartis
Pfizer
Vertex Pharmaceuticals
Merck
Amgen
AbbVie
Astellas
AbbVie Inc Viekira Pak Prescription Volumes Climb, Gilead Sciences, Inc. Harvoni Falls
Bidness Etc.
Fri, 03/13/15 - 12:08 pm
AbbVie
Gilead Sciences
Harvoni
Viekira Pak
hepatitis C
In Case You Missed It, Gilead Sciences, Inc.’s “Bad” News Is Actually Great
Motley Fool
Tue, 03/10/15 - 09:05 am
Gilead Sciences
hepatitis C
AbbVie
Viekira Pak
Sovaldi
Harvoni
AbbVie Projects $3B Sales For HCV Cocktail, But Shares Fall 3%
Seeking Alpha
Mon, 02/2/15 - 03:28 pm
AbbVie
hepatitis C
Viekira Pak
Abbvie Expects $3B In Hepatitis C Drug Sales And 40% Of Insured Customers
Forbes
Fri, 01/30/15 - 11:18 am
AbbVie
hepatitis C
Viekira Pak
Gilead Sciences, Inc. Continues To Reign Over The Hepatitis C Market
Bidness Etc.
Fri, 01/30/15 - 08:05 am
Gilead Sciences
AbbVie
Harvoni
Sovaldi
hepatitis C
Viekira Pak
Can Gilead Beat AbbVie At Its Own Game?
Seeking Alpha
Thu, 01/29/15 - 07:28 am
Gilead
AbbVie
hepatitis C
Harvoni
Sovaldi
Viekira Pak
Express Scripts
AbbVie Hepatitis C Drug Will Be Focus of Profit Report — Earnings Preview
WSJ Online
Tue, 01/27/15 - 04:32 pm
AbbVie
earnings
Viekira Pak
hepatitis C
Gilead Sciences, Inc.’s (GILD) Harvoni Prescriptions Drop 1.8%
Bidness Etc.
Mon, 01/26/15 - 11:46 am
Gilead Sciences
Harvoni
hepatitis C
AbbVie
Viekira Pak
Gilead, AbbVie Hep C Price Cuts Seen Hitting Sales
Investors.com
Wed, 01/21/15 - 05:42 pm
Gilead Sciences
AbbVie
hepatitis C
drug pricing
Viekira Pak
Harvoni
Sovaldi
Pages
« first
‹ previous
1
2
3
next ›
last »